The development of highly active antiretroviral therapy (HAART) especially after 1995, has significantly modified the course of HIV disease, at least in the industrialized world, into a manageable chronic disease with longer survival and improved quality of life in HIV-infected subjects.
HAART generally consists of a dual nucleoside analogue reverse transcriptase inhibitor (NRTI) "backbone" and a third or "cornerstone" drug, such as a nonnucleoside inhibitor (NNRTI) or a protease inhibitor (PI), usually a "boosted" one.The use of a NNRTI as a third drug is less potent and therefore, in most settings not a preferred option, and it is recommended that baseline resistance testing should guide the specific regimen design.
HAART increases CD4+ cell count, decreases levels of HIV RNA, and extends AIDS-free survival, at least in the shorterm. Moreover, HIV suppression with antiretroviral therapy may decrease inflammation and immune activation thought to contribute to higher rates of cardiovascular and other co-morbidities reported in HIV-infected cohorts.
Eradication of HIV infection cannot be achieved with available antiretroviral regimens. This is mainly attributed to the fact that the pool of latently infected CD4+ T-cells is established during the earliest stages of acute HIV infection and persists with a long half-life, even with prolonged suppression of plasma viremia.
It is known that HAART is associated with significant problems, including toxic side effects, development of virological resistance and great financial expense. Up to half of patients on antiretroviral therapy may experience adverse effects of the medications (Fellay et al, 2001) . While most side-effects diminish over time, some can be life-threatening, underscoring the importance of careful patient monitoring (UNAIDS, 2008) .
Due to the intensity of combined antiretroviral treatment and widespread use of HAART, the incidence of many AIDS-related opportunistic infections in patients with advanced HIV infection has significantly decreased but despite dramatic declines in the incidence of opportunistic infections in many resource-rich nations, opportunistic infections remain a leading cause of hospitalization and death for persons with HIV infection.
Among the HIV-associated infections, oral lesions have been recognized as prominent features of HIV infection since the beginning of the epidemic and continue to be important.
Purpose of the present review is to overview the features, prevalence, bacteriology and host response characteristics of periodontal infections in HIV patients, especially as modified during the HAART era.
FEATURES OF PERIODONTAL LESIONS IN HIV INFECTED PATIENTS
HIV infection in adults is linked with the expression of various types of periodontal lesions, which include specific forms of gingivitis and necrotizing periodontal diseases, as well as with possible exacerbation of preexisting periodontal disease Robinson et al, 2002; EC-Clearinghouse, 1993 
2005)
Together with other oral infections, HIV-associated periodontal diseases are regarded as serious complications of HIV infection and have an important diagnostic and prognostic value (EC-Clearinghouse, 1993; Glick et al, 1994a; Shangase et al, 2004; Coogan et al, 2005) . They belong among the earliest clinical features of the infection and could predict progression of HIV disease to AIDS. (Robinson et al, 2002; Coogan et al, 2005) . It should also be mentioned that for patients on antiretroviral therapy, HIV-related oral lesions in general, may suggest possible treatment failure as will be further discussed in the present review. (Margiotta et al, 1999; Ramirez-Amador et al, 2007; Gaitan-Cepeda et al, 2005; Eyeson et al, 2002; Flint et al, 2006) . However, HIV-associated periodontal infections are less common than οral candidiasis and oral hairy leukoplakia and thus not included as criteria in the Centers for Disease Control (CDC) classification (CDC, 1992) . HIV-associated periodontal infections have characteristic clinical appearance which has been well described Greenspan & Greenspan, 2008; Reznik, 2006; Murray 1994) .
Linear Gingival Erythema (LGE) is a form of gingivitis characterized by a distinct fiery red band along the margin of the gingiva (EC-Clearinghouse, 1994) . It is usually associated with anterior teeth, commonly extended to the posterior teeth, accompanied in some cases by bleeding and discomfort (Reznik, 2006 (Murray, 1994; Greenspan & Greenspan, 2008; Reznik, 2006) .
The rapid establishment and course of necrotizing forms of periodontal disease in patients with HIV/AIDS infection, contrary to the gradually progressing periodontal disease in adults in the general population has been outlined in many studies and had not been reported before AIDS epidemic. (Murray et al, 1989; Murray, 1994; Barr et al, 1992; Yeung et al, 1993a) HAART appears to have profoundly influenced the prevalence, severity and course of periodontal lesions as will be further discussed in the next section of the present review (Parveen et al, 2007) .
Risk factors for periodontal disease in HIV-infected individuals besides the general factors of age, smoking, preexisting gingivitis, poor oral hygiene and poor diet, include counts of CD4+ cells (Glick et al, 1994b) , viral load and specific species of microbiota.
Oral opportunistic infections, mainly oral candidiasis (OC) and oral hairy leukoplakia, (OHL) have been associated with CD4+ count in both the pre-HAART and the HAART era in several studies. Based on these findings, low CD4+ counts are now considered as the main risk factor associated with the development of oral lesions and especially of oral candidiasis (Margiotta et al, 1999 (Begg et al, 1996; Patton 2000) . In agreement with the previous studies, Margiota et al (1999) reported that NUP and NUG were significantly associated with CD4+ (Schuman et al, 1998) .
Contradictory results have also been reported in a 2000 study by Patton.
The author reported that the viral load was significantly related to the presence of strongly HIV-associated oral lesions (Patton, 2000) (Shangase et al, 2004) .
As HIV infection gradually becomes a chronic disease, the features and course of chronic periodontal disease in HIV infected patients require more extensive investigation. The "conventional" periodontal diseases in the HAART era have been mentioned in very few studies. (Kroidl et al, 2005; Alpagot et al, 2004) . Conventional periodontitis progresses gradually, causing no or minimal pain or discomfort, being thus undiagnosed, until considerable tissue loss occurs. (Alpagot et al, 2004) . Generally, periodontal inflammation seems to be more severe in cases where CD4+ counts are low (Kroidl et al, 2005) and research nowadays is focused on the accelerated rate with which chronic adult periodontitis presents in seropositive patients. (Lamster et al, 1997) Overall, findings from the above mentioned studies suggest the value of the identification of periodontal disease, even in patients on HAART therapy, in screening the immune suppression, both in diagnosed and undiagnosed HIV infection in adults.
The relation between oral lesions in general and immune and virologic status is still not well established in children. No association was found between the prevalence of oral lesions and immunological status or viral load in children, while there are no data for periodontal diseases (GaitanCepeda et al, 2002) . (Barr et al, 1992; Alpagot et al, 2004) . The type of lesion is often not mentioned, while there is some confusion with the terminology.
Additionally, it is usually unclear whether diagnosis is made by trained Regarding the prevalence of HIV-associated periodontal diseases in the pre-HAART era, data vary widely both in developed and developing countries. Indicatively, reported rates of prevalence for LGE range between 9 and 50%, for NUG between 11 and 25% and for NUP between 1 and 18% (Laskaris et al, 1992; Masouredis et al, 1992; Tukutuku et al, 1990; Glick et al, 1994b) .
After the introduction of HAART, findings from relevant studies also vary
and cannot be compared, partly because of the different types of therapy received by participating patients. Data from representative studies in developed and developing countries concerning adult and pediatric populations are shown in Table1. The effect of HAART on prevalence of HIV-associated periodontal disease is shown in Table 2 . It appears that
HAART is associated with a lower prevalence of HIV-associated periodontal disease in adults. The difference between pre-and post-HAART in most of the studies was found to be statistically significant. Results from studies on the subgingival microbiota in HIV-infected individuals are quite diverse. Some studies have shown that the microbiota is similar in HIV-positive and HIV-negative patients with periodontitis. (Zambon et al, 1990; Brady et al, 1996; Nakou et al, 1997; Tsang & Samaranayake, 2001; Teanpaisan et al, 2001) . Other studies have shown a higher prevalence of putative periodontal pathogens such Treponema denticola, in HIV-positive patients, in comparison to HIVnegative patients, (Murray et al, 1989; Cross & Smith, 1995; Scully et al, 1999; Alpagot et al, 2004) Data from studies in the HAART era, which apply culture-independent molecular techniques are displayed in Table 3 . These techniques as well as other approaches such as proteomics and the study of biofilms will allow an extensive investigation of the microbiota in HIV-infected individuals and the pathogenetic role of "unusual" species. More over the recognition of different microbial profiles in the subgingival area of these patients may be significant. Μore complex microbial profiles were demonstrated in diseased sites than in healthy periodontium in HIVinfected patients (Paster et al, 2002) , while certain combinations of microbes were detected exclusively in HIV-infected individuals. These specific "complexes" may be responsible for chronic periodontitis in this group of patients (Patel et al, 2003) since it is known that changes in the humoral and cellular immunity can affect the establishment and growth of pathogens and the resultant combination of microbes in the subgingival pockets of HIV-positive subjects.
HIV -HOST INTERACTION IN THE PERIODONTAL ENVIRONMENT
Periodontal disease may result from a loss of regulation of immune responses to oral microbiota (Jotwani et al, 2001 ).
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